Why investors love China's loss-making health startups

No profit, no problem: a string of Chinese healthcare firms are riding momentum from strong policy support and a vast consumer market all the way to IPOs. But it's not too late to find a good deal.

Why would scores of investors from across the world want to pile into loss-making companies in a sector that is at the mercy of China's notoriously unpredictable regulators There are 1.3 billion good reasons.

The world's most populous nation is pushing hard to revamp a health sector that has long struggled with an imbalance between growing patient numbers and limited resources. China's growing middle class is demanding better healthcare and the country's leadership, ever mindful of meeting public aspirations for better living standards, is reacting with policy changes that a range of startups are eager to take advantage of.

That's led to strong investments in companies in...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222